Pimobendan improves clinical signs in short term compared to digoxin or placebo in dogs with heart failure due to chronic degenerative mitral valve disease.

Maria Helena Matiko Akao Larsson,Denise Saretta Schwartz,Guilherme Teixeira Goldfeder,Valéria Marinho Costa de Oliveira,Paula Hiromi Itikawa,Ariane Marques Mazini,Priscylla Ramos Rosa Melo,Fabrício Lorenzini Aranha Machado,Francisco Ferreira Lima Júnior,Khadine Kazue Kanayama,Arine Pellegrino,Alexandre Gonçalves Teixeira Daniel,Raul Ossada

Pimobendan improves clinical signs in short term compared to digoxin or placebo in dogs with heart failure due to chronic degenerative mitral valve disease.

2014

Maria Helena Matiko Akao Larsson
Denise Saretta Schwartz
Guilherme Teixeira Goldfeder
Valéria Marinho Costa de Oliveira
Paula Hiromi Itikawa
Ariane Marques Mazini
Priscylla Ramos Rosa Melo
Fabrício Lorenzini Aranha Machado
Francisco Ferreira Lima Júnior
Khadine Kazue Kanayama
Arine Pellegrino
Alexandre Gonçalves Teixeira Daniel
Raul Ossada

Background : Chronic degenerative mitral valve disease (CDMVD) continues to be the most common cause of heart failure (HF) in small breed dogs. Pimobendan (P...

Keywords:

Creatinine
Furosemide
Surgery
Heart failure
Placebo
Chronic degenerative mitral valve disease
Internal medicine
Digoxin
Pimobendan
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations